163 related articles for article (PubMed ID: 28265231)
21. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
[TBL] [Abstract][Full Text] [Related]
22. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
[TBL] [Abstract][Full Text] [Related]
23. Irreversible electroporation ablation: is all the damage nonthermal?
Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
[TBL] [Abstract][Full Text] [Related]
24. Magnetic anchoring and guidance-assisted endoscopic irreversible electroporation for gastric mucosal ablation: a preclinical study in canine model.
Li Q; Gao X; Zhang Y; Han X; Li Z; Zhang Y; Wang Y; Liang L; Chu D; Wu Z; Wang B; Wu R; Lv Y; Ren F
Surg Endosc; 2021 Oct; 35(10):5665-5674. PubMed ID: 33420599
[TBL] [Abstract][Full Text] [Related]
25. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Irreversible Electroporation on the Femur: Experimental Study in a Rabbit Model.
Song Y; Zheng J; Yan M; Ding W; Xu K; Fan Q; Li Z
Sci Rep; 2015 Dec; 5():18187. PubMed ID: 26655843
[TBL] [Abstract][Full Text] [Related]
27. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
[TBL] [Abstract][Full Text] [Related]
28. [Liver regeneration after radiofrequency ablation versus irreversible electroporation].
Li S; Zeng Q; Zhong R; Mao S; Shen L; Wu P
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):66-8. PubMed ID: 25876814
[TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation ablation against subcutaneously implanted VX
Chen R; Li S; Wu L; Qiao X; Luo Y; Zhou X; Qiu S; Chen F
Scott Med J; 2021 Feb; 66(1):23-28. PubMed ID: 33541209
[TBL] [Abstract][Full Text] [Related]
30. Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study.
Lee KW; Lee JM; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Chun HJ; Kim CD; Oh CH; Kim HB
Clin Endosc; 2021 May; 54(3):413-419. PubMed ID: 33076633
[TBL] [Abstract][Full Text] [Related]
31. Technology of irreversible electroporation and review of its clinical data on liver cancers.
Cohen EI; Field D; Lynskey GE; Kim AY
Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
[TBL] [Abstract][Full Text] [Related]
32. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
33. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
Cheng RG; Bhattacharya R; Yeh MM; Padia SA
J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
[TBL] [Abstract][Full Text] [Related]
34. Assessment of various types of US findings after irreversible electroporation in porcine liver: comparison with radiofrequency ablation.
Sugimoto K; Moriyasu F; Kobayashi Y; Kasuya K; Nagakawa Y; Tsuchida A; Hara T; Iobe H; Oshiro H
J Vasc Interv Radiol; 2015 Feb; 26(2):279-87.e3. PubMed ID: 25645416
[TBL] [Abstract][Full Text] [Related]
35. Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer.
White SB; Zhang Z; Chen J; Gogineni VR; Larson AC
J Vasc Interv Radiol; 2018 Dec; 29(12):1764-1769. PubMed ID: 30316676
[TBL] [Abstract][Full Text] [Related]
36. US findings after irreversible electroporation ablation: radiologic-pathologic correlation.
Appelbaum L; Ben-David E; Sosna J; Nissenbaum Y; Goldberg SN
Radiology; 2012 Jan; 262(1):117-25. PubMed ID: 22106355
[TBL] [Abstract][Full Text] [Related]
37. Ablation of hepatic malignant tumors with irreversible electroporation: A systematic review and meta-analysis of outcomes.
Tian G; Zhao Q; Chen F; Jiang T; Wang W
Oncotarget; 2017 Jan; 8(4):5853-5860. PubMed ID: 28009979
[TBL] [Abstract][Full Text] [Related]
38. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
